352 related articles for article (PubMed ID: 31974393)
21. Transcriptomic-metabolomic reprogramming in EGFR-mutant NSCLC early adaptive drug escape linking TGFβ2-bioenergetics-mitochondrial priming.
Thiagarajan PS; Wu X; Zhang W; Shi I; Bagai R; Leahy P; Feng Y; Veigl M; Lindner D; Danielpour D; Yin L; Rosell R; Bivona TG; Zhang Z; Ma PC
Oncotarget; 2016 Dec; 7(50):82013-82027. PubMed ID: 27852038
[TBL] [Abstract][Full Text] [Related]
22. LncRNA MIR503HG is downregulated in Han Chinese with colorectal cancer and inhibits cell migration and invasion mediated by TGF-β2.
Chuo D; Liu F; Chen Y; Yin M
Gene; 2019 Sep; 713():143960. PubMed ID: 31278965
[TBL] [Abstract][Full Text] [Related]
23. TGF-β2 promotes RPE cell invasion into a collagen gel by mediating urokinase-type plasminogen activator (uPA) expression.
Sugioka K; Kodama A; Okada K; Iwata M; Yoshida K; Kusaka S; Matsumoto C; Kaji H; Shimomura Y
Exp Eye Res; 2013 Oct; 115():13-21. PubMed ID: 23810810
[TBL] [Abstract][Full Text] [Related]
24. Integrin signaling potentiates transforming growth factor-beta 1 (TGF-β1) dependent down-regulation of E-Cadherin expression - Important implications for epithelial to mesenchymal transition (EMT) in renal cell carcinoma.
Feldkoren B; Hutchinson R; Rapoport Y; Mahajan A; Margulis V
Exp Cell Res; 2017 Jun; 355(2):57-66. PubMed ID: 28363829
[TBL] [Abstract][Full Text] [Related]
25. Vitamin D regulating TGF-β induced epithelial-mesenchymal transition.
Fischer KD; Agrawal DK
Respir Res; 2014 Nov; 15(1):146. PubMed ID: 25413472
[TBL] [Abstract][Full Text] [Related]
26. High-Mobility Group Box 1 Mediates Epithelial-to-Mesenchymal Transition in Pulmonary Fibrosis Involving Transforming Growth Factor-β1/Smad2/3 Signaling.
Li LC; Li DL; Xu L; Mo XT; Cui WH; Zhao P; Zhou WC; Gao J; Li J
J Pharmacol Exp Ther; 2015 Sep; 354(3):302-9. PubMed ID: 26126535
[TBL] [Abstract][Full Text] [Related]
27. The natural compound codonolactone attenuates TGF-β1-mediated epithelial-to-mesenchymal transition and motility of breast cancer cells.
Fu J; Ke X; Tan S; Liu T; Wang S; Ma J; Lu H
Oncol Rep; 2016 Jan; 35(1):117-26. PubMed ID: 26549400
[TBL] [Abstract][Full Text] [Related]
28. Sanguiin H6 suppresses TGF-β induction of the epithelial-mesenchymal transition and inhibits migration and invasion in A549 lung cancer.
Ko H; Jeon H; Lee D; Choi HK; Kang KS; Choi KC
Bioorg Med Chem Lett; 2015 Dec; 25(23):5508-13. PubMed ID: 26508552
[TBL] [Abstract][Full Text] [Related]
29. 1-Methyl-D-tryptophan potentiates TGF-β-induced epithelial-mesenchymal transition in T24 human bladder cancer cells.
Brito RB; Malta CS; Souza DM; Matheus LH; Matos YS; Silva CS; Ferreira JM; Nunes VS; França CM; Dellê H
PLoS One; 2015; 10(8):e0134858. PubMed ID: 26267811
[TBL] [Abstract][Full Text] [Related]
30. Acidosis-Induced TGF-β2 Production Promotes Lipid Droplet Formation in Dendritic Cells and Alters Their Potential to Support Anti-Mesothelioma T Cell Response.
Trempolec N; Degavre C; Doix B; Brusa D; Corbet C; Feron O
Cancers (Basel); 2020 May; 12(5):. PubMed ID: 32438640
[TBL] [Abstract][Full Text] [Related]
31. Blockade of Jagged/Notch pathway abrogates transforming growth factor β2-induced epithelial-mesenchymal transition in human retinal pigment epithelium cells.
Chen X; Xiao W; Liu X; Zeng M; Luo L; Wu M; Ye S; Liu Y
Curr Mol Med; 2014 May; 14(4):523-34. PubMed ID: 24694299
[TBL] [Abstract][Full Text] [Related]
32. TGF-β1 and TGF-β2 abundance in liver diseases of mice and men.
Dropmann A; Dediulia T; Breitkopf-Heinlein K; Korhonen H; Janicot M; Weber SN; Thomas M; Piiper A; Bertran E; Fabregat I; Abshagen K; Hess J; Angel P; Coulouarn C; Dooley S; Meindl-Beinker NM
Oncotarget; 2016 Apr; 7(15):19499-518. PubMed ID: 26799667
[TBL] [Abstract][Full Text] [Related]
33. Combined treatment with zingerone and its novel derivative synergistically inhibits TGF-β1 induced epithelial-mesenchymal transition, migration and invasion of human hepatocellular carcinoma cells.
Kim YJ; Jeon Y; Kim T; Lim WC; Ham J; Park YN; Kim TJ; Ko H
Bioorg Med Chem Lett; 2017 Feb; 27(4):1081-1088. PubMed ID: 28110870
[TBL] [Abstract][Full Text] [Related]
34. Implication of Smad2 and Smad3 in transforming growth factor-β-induced posterior capsular opacification of human lens epithelial cells.
Li H; Yuan X; Li J; Tang X
Curr Eye Res; 2015 Apr; 40(4):386-97. PubMed ID: 24911914
[TBL] [Abstract][Full Text] [Related]
35. Oridonin prevents epithelial-mesenchymal transition and TGF-β1-induced epithelial-mesenchymal transition by inhibiting TGF-β1/Smad2/3 in osteosarcoma.
Sun Y; Jiang X; Lu Y; Zhu J; Yu L; Ma B; Zhang Q
Chem Biol Interact; 2018 Dec; 296():57-64. PubMed ID: 30243739
[TBL] [Abstract][Full Text] [Related]
36. Calcitriol inhibits migration and invasion of renal cell carcinoma cells by suppressing Smad2/3-, STAT3- and β-catenin-mediated epithelial-mesenchymal transition.
Xu S; Zhang ZH; Fu L; Song J; Xie DD; Yu DX; Xu DX; Sun GP
Cancer Sci; 2020 Jan; 111(1):59-71. PubMed ID: 31729097
[TBL] [Abstract][Full Text] [Related]
37. Nobiletin inhibits epithelial-mesenchymal transition of human non-small cell lung cancer cells by antagonizing the TGF-β1/Smad3 signaling pathway.
Da C; Liu Y; Zhan Y; Liu K; Wang R
Oncol Rep; 2016 May; 35(5):2767-74. PubMed ID: 26986176
[TBL] [Abstract][Full Text] [Related]
38. Transforming growth factor-β1 stimulates hedgehog signaling to promote epithelial-mesenchymal transition after kidney injury.
Lu H; Chen B; Hong W; Liang Y; Bai Y
FEBS J; 2016 Oct; 283(20):3771-3790. PubMed ID: 27579669
[TBL] [Abstract][Full Text] [Related]
39. TGF-β1-induced epithelial-mesenchymal transition and acetylation of Smad2 and Smad3 are negatively regulated by EGCG in human A549 lung cancer cells.
Ko H; So Y; Jeon H; Jeong MH; Choi HK; Ryu SH; Lee SW; Yoon HG; Choi KC
Cancer Lett; 2013 Jul; 335(1):205-13. PubMed ID: 23419524
[TBL] [Abstract][Full Text] [Related]
40. Transforming growth factor-β 1 enhances the invasiveness of breast cancer cells by inducing a Smad2-dependent epithelial-to-mesenchymal transition.
Lv ZD; Kong B; Li JG; Qu HL; Wang XG; Cao WH; Liu XY; Wang Y; Yang ZC; Xu HM; Wang HB
Oncol Rep; 2013 Jan; 29(1):219-25. PubMed ID: 23129177
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
